Stephen B Shrewsbury's Net Worth
$7.49 Million
Who is Stephen B Shrewsbury?
Stephen B Shrewsbury has an estimated net worth of $7.49 Million. This is based on reported shares across multiple companies, which include MAP Pharmaceuticals, Inc., AVI BIOPHARMA INC, AQUINOX PHARMACEUTICALS, INC, and IMPEL NEUROPHARMA INC.
SEC CIK
Stephen B Shrewsbury's CIK is 0001413821
Past Insider Trading and Trends
2021 was Stephen B Shrewsbury's most active year for acquiring shares with 4 total transactions. Stephen B Shrewsbury's most active month to acquire stocks was the month of December. 2021 was Stephen B Shrewsbury's most active year for disposing of shares, totalling 3 transactions. Stephen B Shrewsbury's most active month to dispose stocks was the month of August. 2008 saw Stephen B Shrewsbury paying a total of $524,800.00 for 40,000 shares, this is the most they've acquired in one year. In 2021 Stephen B Shrewsbury cashed out on 73,384 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MAP Pharmaceuticals, Inc. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 22
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AVI BIOPHARMA INC (SRPT) Snapshot price: $128.92
SVP/Regulatory Affairs
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 9
| |||
Form 4/A
|
∞
| 60K |
—
|
—
| 60K |
Jan 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AQUINOX PHARMACEUTICALS, INC (NLTX) No price found
CMO; Senior VP Clinical Dev.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
IMPEL NEUROPHARMA INC (IMPL) No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +33.53% | 24.61K |
$1.97 | $48,473.82 | 97.99K |
Mar 29
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 4
|
∞
| 73.38K |
$2.72 | $199,719.90 | 73.38K |
Sep 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||